Join CSTE   |   Career Center   |   Print Page   |   Contact Us   |   Report Abuse   |   Sign In
Overview

CSTE position statements represent the documentation and analysis of policy issues affecting public health and can cover any issue of importance to CSTE members. Position statements may take the form of general policy statements or call for placing health conditions under standardized surveillance. Position statements are submitted each spring and then discussed and voted on by the CSTE membership at the Annual Conference in June. Position statement authors must be active CSTE members, although associate members may be co-authors.

2017 Position Statements (members-only): Click Here to View
View past position statements by clicking here.
View the 2017 Position Statement Timeline.

**2017 Position Statement Webinars - Scheduled**

CSTE has scheduled several position statement discussion webinars before the formal discussions that will take place in Steering Committee sessions at the 2017 CSTE Annual Conference. The purpose of these discussions is to allow more time for members and position statement authors to interact and engage in discussions of submitted position statements.

During each webinar, position statements will have a designated discussion time. During this time frame, the authors will give a 5-7 minute summary of the position statement and then CSTE members will be invited to provide feedback and discuss the position statement (up to 20 minutes per Position Statement). At the end of each webinar, participants will be encouraged to send additional feedback to the primary author. Member discussions will continue at the Annual Conference at informal roundtable sessions as well as during the formal Steering Committee voting sessions.

The webinars are scheduled as follows (detailed agendas are below)*:
May 9 at 3:00-4:30pm ET
May 12 at 1:30-3:00pm ET
May 15 at 3:00-4:30pm ET
May 18 at 3:00-4:00pm ET (if needed)
The feedback received on these webinars has been incredibly beneficial to the position statement process and we look forward to your participation this year.
*Specific webinar agendas may be subject to change. Please check back on this website for the most up-to-date schedules.
2017 Position Statements (members-only): Click Here to View
17-CC-01 – Support for Use of the CDC’s Model Aquatic Health Code (MAHC) as a Resource and Guidance Document by State, Territorial, and Local Jurisdictions Regulating Public Aquatic Facilities
17-ID-01 – Revision to the Standardized Surveillance and Case Definition for Acute Flaccid Myelitis
17-ID-02 – Revision for the Standardized Case Definition, Case Classification, and National Surveillance for Anthrax
17-ID-03 – Standardized Case Definition for Candida auris
17-ID-04 – Public Health Reporting and National Notification of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE)
17-ID-05 – Surveillance for perinatal HIV exposure: Update
17-ID-06 – Transgender HIV Surveillance
17-ID-07 – Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections
17-ID-08 – Public Health Reporting and National Notification of Perinatal Hepatitis C Virus Infection
17-ID-09 – Establishing a Case Definition for Latent TB Infection (TB Infection)
17-ID-10 – Public Health Reporting and National Notification for Shiga Toxin-Producing Escherichia coli (STEC)
17-ID-11 – Update to Public Health Reporting and National Notification for Syphilis
CSTE Position Statement Discussion I
Recording Link : https://cste.webex.com/cste/lsr.php?RCID=9b365ccf4865f8a8199fca140ef0950e
Date: May 9 at 3:00-4:30 pm ET
Moderator: Rich Danila
Agenda
3:00: Introduction and Housekeeping
3:05: 17-ID-03 – Standardized Case Definition for Candida auris
3:25: 17-ID-04 – Public Health Reporting and National Notification of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE)
3:45: 17-CC-01 – Support for Use of the CDC’s Model Aquatic Health Code (MAHC) as a Resource and Guidance Document by State, Territorial, and Local Jurisdictions Regulating Public Aquatic Facilities
4:05: 17-ID-08 – Public Health Reporting and National Notification of Perinatal Hepatitis C Virus Infection
 
CSTE Position Statement Discussion II
Recording Link: https://cste.webex.com/cste/lsr.php?RCID=ee46d45821f0c1f67236268db30ae1ad
Date: May 12 at 1:30-3:00 pm ET
Moderator: Kristy Bradley
Agenda
1:30: Introduction and Housekeeping
1:35: 17-ID-06 – Transgender HIV Surveillance
1:55: 17-ID-05 – Surveillance for perinatal HIV exposure: Update
2:15: 17-ID-07 – Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections
2:35: 17-ID-09 – Establishing a Case Definition for Latent TB Infection (TB Infection)
 
CSTE Position Statement Discussion III
Recording Link: https://cste.webex.com/cste/lsr.php?RCID=ae2ea92e40dc87f96d033508b0e524c5
Date: May 15 at 3:00-4:30 pm ET
Moderator: Kristy Bradley
Agenda
3:00: Introduction and Housekeeping
3:05: 17-ID-01 – Revision to the Standardized Surveillance and Case Definition for Acute Flaccid Myelitis
3:25: 17-ID-11 – Update to Public Health Reporting and National Notification for Syphilis
3:45: 17-ID-02 – Revision for the Standardized Case Definition, Case Classification, and National Surveillance for Anthrax
4:05: 17-ID-10 – Public Health Reporting and National Notification for Shiga Toxin-Producing Escherichia coli (STEC)
CSTE Position Statement Discussion IV (if needed)
Date: May 18 at 3:00-4:00 pm ET
Moderator: TBD
Agenda – TBD
Webinar Information
To join the webinar
1. Go to https://cste.webex.com/cste/k2/j.php?MTID=tc049b365ee7b75e330b042790486e4b7
2. Enter your name and email address.
3. Enter the session password: ps2017.
4. Click "Join Now".
5. Follow the audio instructions that appear on your screen.

Position statements must be submitted by an active CSTE member using the appropriate template and by the deadline. The submission deadline for ordinary process position statements is 13 weeks before the June business meeting on Thursday, March 9, 2017.
PDF versions of the 2017 templates for submitting position statements are available below. If you plan to submit a position statement and would like an editable Word version of the template, please email positionstatements@cste.org and include:
  • the type of template you need, and
  • the topic of your position statement.
2017 Position Statement Templates (for viewing purposes only)
Policy
Standardized surveillance for diseases or conditions
Standardized surveillance for healthcare-associated diseases or conditions through the National Healthcare Safety Network
*To download a template, please contact positionstatements@cste.org.
Changes to 2017 Position Statement Templates
Please note that CSTE has instituted word count limits for each narrative section in all position statement templates. Exact word limits are included in each sections’ instructions. Supplemental information may be included in appendices but will be considered as reference only and will not be considered as part of the position statement for voting purposes.
Author Information
Authors seeking to update an existing standardized surveillance case definition should reference previous CSTE position statements for the condition and describe the proposed updates in the position statement. Authors are also encouraged to seek input from appropriate subject matter experts at the state, local, and federal levels during the position statement writing process. The template must be completed in its entirety for both updated and new case definitions. Final position statements should be able to "stand alone” and contain all current information required to implement surveillance for the disease or condition.
View submitting author responsibilities.
There are three mechanisms to submit a position statement for consideration by the CSTE membership and discussion at the CSTE Business Meeting: ordinary process, expedited handling, and presidential review. Please see the requirements for each and the 2017 submission timeline as an example for more details.

Submission
Position statements should be submitted using the appropriate template. Submitted statements using the incorrect template will not be accepted by the National Office.

Templates
The format for the three types of position statements is briefly described below. Per changes noted above, word count limits are now included for all narrative sections of each position statement template.

Policy resolutions:
  1. Statement of the problem
  2. Statement of the desired action(s) to be taken
  3. Public health impact
  4. Revision history
  5. References
  6. Coordination
  7. Author Information
Standardized surveillance for diseases or conditions:
  1. Statement of the problem
  2. Background and justification
  3. Statement of the desired action(s) to be taken
  4. Goals of surveillance
  5. Methods for surveillance
  6. Criteria for case identification
  7. Case definition for case classification
  8. Period of surveillance
  9. Data sharing/release and print criteria
  10. Revision history
  11. References
  12. Coordination
  13. Author Information
Placing healthcare-associated diseases or conditions under standardized surveillance through the National Healthcare Safety Network:
  1. Statement of the problem
  2. Background and justification
  3. Statement of the desired action(s) to be taken
  4. Goals of surveillance
  5. Methods for surveillance
  6. Case and denominator definitions or risk adjustment
  7. Proposed circumstances for standardized surveillance and reporting
  8. Narrative: Public health surveillance vision, proposed priorities, and strategy for future expansion or decrease in surveillance
  9. Data sharing/release and print criteria
  10. Revision history
  11. References
  12. Coordination
  13. Author Information

Interim position statements
Urgent or time-sensitive issues that must be addressed between annual business meetings may be submitted as interim position statements. Interim position statements are approved by the CSTE Executive Board and immediately become official policy of CSTE until the next CSTE Business Meeting, when they must be ratified or they will become null. Interim position statements are posted to the CSTE website immediately after approval by the Executive Board.

2017 Position Statement Webinars have not yet been scheduled.

Approval process
At the CSTE Annual Conference, all CSTE members are encouraged to attend the position statement discussions organized by CSTE Steering Committees, where each statement is presented by the author, discussed, and voted on. An author (usually, the submitting author) is required to be at the Annual Conference to present the statement. Dates and times of the Steering Committee discussions vary but are available in the yearly CSTE Annual Conference agenda.

Position statements are put to two votes by the appropriate Steering Committee, the first to approve the position statement and the second to add the position statement to the CSTE Consent Calendar. The CSTE Consent Calendar is a method for position statements that have been deemed non-controversial to be voted upon all at once by the Council at the CSTE Business Meeting. In order for a Steering Committee to consider adding a position statement the CSTE Consent Calendar, a quorum of CSTE members must be met during the voting process. A quorum for position statement purposes is defined as at least one Active Member from ten or more states or U.S. territories represented in any Steering Committee Session.

Position statements approved by the Steering Committees are brought to the CSTE Business Meeting for final approval. This meeting occurs annually at the CSTE Annual Conference and typically occurs Thursday morning. At this meeting, representatives from state and territorial health agencies vote on the position statements. Each state and territory is given one vote.

To review the policy on the position statement approval process, please view the CSTE Policies and Procedures Manual.

After approval
Once approved, all position statements become CSTE policy and will be posted on the CSTE website. The submitting author will be responsible for tracking the position statement during the year following its adoption. By May 1 of the year following adoption of a position statement, the original submitter will be asked to report back to the CSTE Executive Board on the status and impact of the position statement. In addition, the CSTE National Office will follow up with agencies that have been contacted for information or response as listed on each position statement.
Association Management Software Powered by YourMembership  ::  Legal